WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (37)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dzenko, K. A.
Right arrow Articles by Pachter, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dzenko, K. A.
Right arrow Articles by Pachter, J. S.

 Previous Article  |  Next Article 

The Journal of Neuroscience, December 1, 2001, 21(23):9214-9223

The Chemokine Receptor CCR2 Mediates the Binding and Internalization of Monocyte Chemoattractant Protein-1 along Brain Microvessels

Kirk A. Dzenko1, Anuska V. Andjelkovic1, William A. Kuziel2, and Joel S. Pachter1

1 Blood-Brain Barrier Laboratory, Department of Pharmacology, University of Connecticut Health Center, Farmington, Connecticut 06030, and 2 Department of Molecular Genetics and Microbiology and Institute for Cellular and Molecular Biology, University of Texas, Austin, Texas 78712

Previous results from this laboratory revealed the presence of high-affinity saturable binding sites for monocyte chemoattractant protein-1 (MCP-1) along human brain microvessels (Andjelkovic et al., 1999; Andjelkovic and Pachter, 2000), which suggested that CC chemokine receptor 2 (CCR2), the recognized receptor for this chemokine, was expressed by the brain microvascular endothelium. To test the role of CCR2 directly in mediating MCP-1 interactions with the brain microvasculature, we assessed MCP-1 binding activity in murine brain microvessels isolated from wild-type mice and from CCR2 (-/-) mice engineered to lack this receptor. Results demonstrate that MCP-1 binding is greatly attenuated in microvessels prepared from CCR2 (-/-) mice compared with wild-type controls. Moreover, microvessels from wild-type mice exhibited MCP-1-induced downmodulation in MCP-1 binding and a recovery of binding activity that was not dependent on de novo protein synthesis. Furthermore, MCP-1 was shown to be internalized within wild-type microvessels, but not within microvessels obtained from CCR2 (-/-) mice, additionally demonstrating that CCR2 is obligatory for MCP-1 endocytosis. Last, internalization of MCP-1, but not transferrin, was observed to be inhibited by disruption of caveolae. Internalized MCP-1 also colocalized at some sites with caveolin-1, a major protein of caveolae, implying that this chemokine is endocytosed, in part, via nonclathrin-coated vesicles. These results prompt consideration that MCP-1 signals may be relayed across the blood-brain barrier by highly specialized interactions of this chemokine with its cognate receptor, CCR2, along brain microvascular endothelial cells.

Key words: MCP-1; receptors; brain; microvessels; blood-brain barrier; endothelial cells


Copyright © 2001 Society for Neuroscience  0270-6474/01/21239214-10$05.00/0


This article has been cited by other articles:


Home page
BrainHome page
A. Mildner, M. Mack, H. Schmidt, W. Bruck, M. Djukic, M. D. Zabel, A. Hille, J. Priller, and M. Prinz
CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system
Brain, June 16, 2009; (2009) awp144v1.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Song, S. Ge, and J. S. Pachter
Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells
Blood, February 15, 2007; 109(4): 1515 - 1523.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. G. Galvez, L. Genis, S. Matias-Roman, S. A. Oblander, K. Tryggvason, S. S. Apte, and A. G. Arroyo
Membrane Type 1-Matrix Metalloproteinase Is Regulated by Chemokines Monocyte-Chemoattractant Protein-1/CCL2 and Interleukin-8/CXCL8 in Endothelial Cells during Angiogenesis
J. Biol. Chem., January 14, 2005; 280(2): 1292 - 1298.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. Furlan, S. Orlando, C. Laudanna, M. Resnati, V. Basso, F. Blasi, and A. Mondino
The soluble D2D388-274 fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion
J. Cell Sci., June 15, 2004; 117(14): 2909 - 2916.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Rose, J. F. Foley, P. M. Murphy, and S. Venkatesan
On the Mechanism and Significance of Ligand-induced Internalization of Human Neutrophil Chemokine Receptors CXCR1 and CXCR2
J. Biol. Chem., June 4, 2004; 279(23): 24372 - 24386.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Heil, T. Ziegelhoeffer, S. Wagner, B. Fernandez, A. Helisch, S. Martin, S. Tribulova, W. A. Kuziel, G. Bachmann, and W. Schaper
Collateral Artery Growth (Arteriogenesis) After Experimental Arterial Occlusion Is Impaired in Mice Lacking CC-Chemokine Receptor-2
Circ. Res., March 19, 2004; 94(5): 671 - 677.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ge and J. S. Pachter
Caveolin-1 Knockdown by Small Interfering RNA Suppresses Responses to the Chemokine Monocyte Chemoattractant Protein-1 by Human Astrocytes
J. Biol. Chem., February 20, 2004; 279(8): 6688 - 6695.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. M. Stamatovic, R. F. Keep, S. L. Kunkel, and A. V. Andjelkovic
Potential role of MCP-1 in endothelial cell tight junction `opening': signaling via Rho and Rho kinase
J. Cell Sci., November 15, 2003; 116(22): 4615 - 4628.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Belnoue, M. Kayibanda, J.-C. Deschemin, M. Viguier, M. Mack, W. A. Kuziel, and L. Renia
CCR5 deficiency decreases susceptibility to experimental cerebral malaria
Blood, June 1, 2003; 101(11): 4253 - 4259.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Gaupp, D. Pitt, W. A. Kuziel, B. Cannella, and C. S. Raine
Experimental Autoimmune Encephalomyelitis (EAE) in CCR2-/- Mice: Susceptibility in Multiple Strains
Am. J. Pathol., January 1, 2003; 162(1): 139 - 150.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Lubeseder-Martellato, E. Guenzi, A. Jorg, K. Topolt, E. Naschberger, E. Kremmer, C. Zietz, E. Tschachler, P. Hutzler, M. Schwemmle, et al.
Guanylate-Binding Protein-1 Expression Is Selectively Induced by Inflammatory Cytokines and Is an Activation Marker of Endothelial Cells during Inflammatory Diseases
Am. J. Pathol., November 1, 2002; 161(5): 1749 - 1759.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-